Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Other Solid Tumors

Pediatric tumor patients scanned with a long axial field of view scanner – a single center experience on the use of lower administered doses of [18F]FDG

Ali Afshar-Oromieh, Carola Bregenzer, Korbinian Krieger, Clemens Mingels, Hasan Sari, Konstantinos Zeimpekis, Nasir Gözlügöl, Ângelo Cardoso, Ângela Mendes and Axel Rominger
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 242020;
Ali Afshar-Oromieh
1Inselpital, Bern
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carola Bregenzer
1Inselpital, Bern
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Korbinian Krieger
2Inselspital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clemens Mingels
3University of California Davis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hasan Sari
4Siemens Healthineers International AG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Konstantinos Zeimpekis
5Department of Nuclear Medicine, Inselspital Bern
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nasir Gözlügöl
6Inselspital, Bern
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ângelo Cardoso
7Department of Nuclear Medicine, Inselspital, University Hospital Bern, University of Bern
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ângela Mendes
8Department of Nuclear Medicine, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Axel Rominger
6Inselspital, Bern
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

242020

Introduction: The administered activity for [18F]FDG-PET/CT in pediatric patients has been a topic of ongoing discussion. Current guidelines suggest a dose range of 3.7-5.2 MBq/kg body weight (BW). With the technological advancements in the latest generation scanners, there is a promising opportunity to reduce the administered dose. In this evaluation, we present our experiences with pediatric tumor patients who underwent PET/CT scans using reduced doses on a long axial field of view (LAFOV) scanner.

Methods: 25 [18F]FDG-PET/CT conducted with LAFOV-PET/CT scanner (field-of-view: 106 cm) in 18 children and adolescences (age < 18 y/o) were included in this retrospective analysis. Amongst them, three groups were identified depending on the administered activity: 1 MBq per kg body weight, 2 MBq/kg BW and 3 MBq/kg BW. Acquisition duration was 10 minutes for all groups starting 1h post injection. In addition to the before-mentioned three groups, a fourth group was created by simulating 0.5 MBq/kg BW by artificially reconstructing all images conducted with the before-mentioned activities. In addition, 12 scans conducted with a high-end standard axial FOV scanner (field-of-view: 26.3 cm) in nine children were comparatively assessed. The quality of all scans was assessed in a blinded manner by four readers using a 5-point Likert scale, where a score of 5 indicated the best quality and a score of 1 indicated the worst. The differences were evaluated using the Kruskal-Wallis test, and a p-value lower than 0.05 was deemed to be statistically significant.

Results: The mean (± SD) Likert scale of the different groups were as follows: 2.7 ± 0.66 for 0.5 MBq/kg; 3.4 ± 0.75 for 1 MBq/kg; 4.4 ± 0.53 for 2 MBq/kg, 5.0 ± 0 for 3 MBq/kg and 2.88 ± 0.79 for the group acquired on a standard FOV scanner. There was a significant association between higher activities and higher Likert scales: p=0.004 for the comparison between group 1 MBq/kg vs. group 0.5 MBq/kg, p=0.002 for the comparison between group 2 MBq/kg vs. group 1 MBq/kg and p=0.013 for the comparison between group 3 MBq/kg vs. group 2 MBq/kg. No significant difference was found between the 1 MBq/kg group and the group scanned with the high-end standard FOV scanner (p = 0.23). On the other hand, the image quality of the 0.5 MBq/kg group was lower compared to the standard FOV group (p=0.013).

Conclusions: The image quality achieved using a dose of 3 MBq/kg with the LAFOV-PET/CT scanner was exceptional, despite being lower than the recommended dose stated in the guidelines, which were established based on data from standard FOV scanners. As anticipated, image quality noticeably declined when lower doses of [18F]FDG were used. However, scans performed with a dose of 1 MBq/kg on the LAFOV-PET/CT scanner yielded comparable quality to scans conducted with a full dose on a standard FOV scanner. Depending on the specific clinical requirement, the dose can be further adjusted to meet the clinical needs.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pediatric tumor patients scanned with a long axial field of view scanner â&#128;&#147; a single center experience on the use of lower administered doses of [18F]FDG
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Pediatric tumor patients scanned with a long axial field of view scanner – a single center experience on the use of lower administered doses of [18F]FDG
Ali Afshar-Oromieh, Carola Bregenzer, Korbinian Krieger, Clemens Mingels, Hasan Sari, Konstantinos Zeimpekis, Nasir Gözlügöl, Ângelo Cardoso, Ângela Mendes, Axel Rominger
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 242020;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Pediatric tumor patients scanned with a long axial field of view scanner – a single center experience on the use of lower administered doses of [18F]FDG
Ali Afshar-Oromieh, Carola Bregenzer, Korbinian Krieger, Clemens Mingels, Hasan Sari, Konstantinos Zeimpekis, Nasir Gözlügöl, Ângelo Cardoso, Ângela Mendes, Axel Rominger
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 242020;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Impact of dual tracer study to differentiate malignant vs benign peritoneal diseases.
  • Initial Clinical Experience with 177Lu-EB-FAPI Radioligand Therapy in Patients with End-Stage Metastatic Cancers
  • Preliminary Clinical Investigation of [68Ga] Ga or [177Lu] Lu-Labeled DOTA-IBA for the Diagnosis and Treatment of Bone Metastasis
Show more Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Other Solid Tumors

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire